[Role of VEGFR-TKIs in the treatment of renal cell carcinoma].

Subjects

Subjects :

Humans
Niacinamide analogs & derivatives
Phenylurea Compounds
Protein-Tyrosine Kinases antagonists & inhibitors
Receptors, Vascular Endothelial Growth Factor antagonists & inhibitors
Sorafenib
Sunitinib
Angiogenesis Inhibitors adverse effects
Angiogenesis Inhibitors pharmacology
Angiogenesis Inhibitors therapeutic use
Antineoplastic Agents adverse effects
Antineoplastic Agents pharmacology
Antineoplastic Agents therapeutic use
Benzenesulfonates adverse effects
Benzenesulfonates pharmacology
Benzenesulfonates therapeutic use
Carcinoma, Renal Cell drug therapy
Indoles adverse effects
Indoles pharmacology
Indoles therapeutic use
Kidney Neoplasms drug therapy
Molecular Targeted Therapy
Pyridines adverse effects
Pyridines pharmacology
Pyridines therapeutic use
Pyrroles adverse effects
Pyrroles pharmacology
Pyrroles therapeutic use

Details

Language :

Japanese

ISSN :

0385-2385

Volume :

54

Issue :

5

Database :

MEDLINE

Journal :

Nihon Jinzo Gakkai shi

Publication Type :

Academic Journal

Accession number :

22991835